BR9914996A - Stimulating compositions for improved growth - Google Patents

Stimulating compositions for improved growth

Info

Publication number
BR9914996A
BR9914996A BR9914996-6A BR9914996A BR9914996A BR 9914996 A BR9914996 A BR 9914996A BR 9914996 A BR9914996 A BR 9914996A BR 9914996 A BR9914996 A BR 9914996A
Authority
BR
Brazil
Prior art keywords
improved
improved growth
release
growth
stimulating compositions
Prior art date
Application number
BR9914996-6A
Other languages
Portuguese (pt)
Inventor
Chung Shih
Thomas J Kennedy
Peter James Knight
Daniel S Robins
Zezhi Jesse Shao
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of BR9914996A publication Critical patent/BR9914996A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Patente de Invenção:<B>''COMPOSIçõES ESTIMULANTES DE CRESCIMENTO MELHORADO''<D>. Um estimulante de peso e crescimento melhorado para animais domésticos tais como gado, porcos e ovelhas compreendendo um agente anabólico que é subcutaneamente administrado na forma de uma formulação de implante de liberação dual. Ganhos aumentados são particularmente melhorados, quando zeranol é administrado em uma formulação de liberação imediata e de liberação controlada que permite uma injeção de dosagem a um só tempo.Invention Patent: <B> '' STIMULANT COMPOSITIONS FOR IMPROVED GROWTH '' <D>. An improved weight and growth stimulant for domestic animals such as cattle, pigs and sheep comprising an anabolic agent that is subcutaneously administered in the form of a dual release implant formulation. Increased gains are particularly improved when zeranol is administered in an immediate-release and controlled-release formulation that allows a single dose injection.

BR9914996-6A 1998-11-04 1999-11-02 Stimulating compositions for improved growth BR9914996A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18594498A 1998-11-04 1998-11-04
PCT/US1999/023993 WO2000025743A2 (en) 1998-11-04 1999-11-02 Improved growth stimulant compositions

Publications (1)

Publication Number Publication Date
BR9914996A true BR9914996A (en) 2001-07-10

Family

ID=22683037

Family Applications (2)

Application Number Title Priority Date Filing Date
BR9914996-6A BR9914996A (en) 1998-11-04 1999-11-02 Stimulating compositions for improved growth
BRPI9914996-6 BRPI9914996B8 (en) 1998-11-04 1999-11-02 Anabolic implant composition and process to stimulate increased growth rate, greater amount of growth and greater feed efficiency in an animal.

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI9914996-6 BRPI9914996B8 (en) 1998-11-04 1999-11-02 Anabolic implant composition and process to stimulate increased growth rate, greater amount of growth and greater feed efficiency in an animal.

Country Status (11)

Country Link
AR (1) AR025133A1 (en)
AU (1) AU777393B2 (en)
BR (2) BR9914996A (en)
CA (1) CA2348841C (en)
CO (1) CO5140100A1 (en)
CR (1) CR6351A (en)
MY (1) MY134868A (en)
PE (1) PE20001092A1 (en)
TW (1) TWI250027B (en)
WO (1) WO2000025743A2 (en)
ZA (1) ZA200103494B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020131988A1 (en) * 1999-12-16 2002-09-19 Foster Todd P. Pharmaceutical implant containing immediate-release and sustained-release components and method of administration
US6953586B1 (en) * 2000-06-08 2005-10-11 Ivy Animal Health, Inc. Growth promoting pharmaceutical implant
EP4000688A1 (en) 2020-11-19 2022-05-25 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Process for the preparation of trenbolone acetate having a definite particle size distribution
EP4001288A1 (en) 2020-11-19 2022-05-25 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Process for the preparation of trenbolone acetate having a definite particle size distribution and a irregular hexagon plates crystal habit
EP4001289B1 (en) 2020-11-19 2023-05-03 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Improved process for the preparation of trenbolone and/or trenbolone acetate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2573307B1 (en) * 1984-11-22 1988-06-10 Virbac Ctre Rech Biolog EXTENDED RELEASE ANABOLIZING IMPLANTS
US4670249A (en) * 1985-04-12 1987-06-02 International Minerals & Chemical Corp. Growth-promoting compositions
US5219572A (en) * 1989-03-17 1993-06-15 Pitman-Moore, Inc. Controlled release delivery device for macromolecular proteins
US5747060A (en) * 1996-03-26 1998-05-05 Euro-Celtique, S.A. Prolonged local anesthesia with colchicine
US5874098A (en) * 1997-05-28 1999-02-23 Ivy Laboratories, Inc. Pellet implant system

Also Published As

Publication number Publication date
CA2348841A1 (en) 2000-05-11
BRPI9914996B8 (en) 2021-07-06
AR025133A1 (en) 2002-11-13
WO2000025743A3 (en) 2000-08-24
AU777393B2 (en) 2004-10-14
CA2348841C (en) 2007-04-17
WO2000025743A2 (en) 2000-05-11
BRPI9914996A (en) 2001-07-10
PE20001092A1 (en) 2000-10-31
ZA200103494B (en) 2002-07-30
BRPI9914996B1 (en) 2011-11-01
TWI250027B (en) 2006-03-01
CO5140100A1 (en) 2002-03-22
MY134868A (en) 2007-12-31
AU3096700A (en) 2000-05-22
CR6351A (en) 2003-11-20

Similar Documents

Publication Publication Date Title
CY1105000T1 (en) USE OF SPINOSADI OR A COMPOSITION OF SPINOSADI CONTENT
BR0306982A (en) Compound or a pharmaceutically acceptable salt thereof, pharmaceutical composition, methods to reduce the calcium conductance of a cell capsaicin receptor, to inhibit the binding of vanilloid ligand to a capsaicin receptor in vitro and in a patient, to treat a condition responsive to modulation of the capsaicin receptor in a patient, to treat pain in a patient, to treat itching in a patient, to treat coughing or hiccups in a patient, to promote weight loss in an obese patient, and to determine the presence or absence capsaicin receptor in a sample, packaged pharmaceutical preparation, and use of a compound
BR0015974A (en) Use of levetiracetam, pharmaceutical composition, use of a pharmaceutical composition and methods to treat a patient administered with an amount of at least one compound and a disease and to selectively potentiate the therapeutic effect of a compound
BR9715022A (en) Method for treating prostate disease using systematic and / or prolonged release of vitamin D formulations
BR0317747A (en) Method of concomitant therapeutic treatment of an individual, pharmaceutical composition, kit, use of a first agent and a second agent, and methods of preventing or treating amyloid-b-related disease, alzheimer&#39;s disease and mild cognitive impairment
BRPI0412211A (en) controlled release compositions
BR0316305A (en) A compound or a pharmaceutically acceptable salt thereof, methods for treating pain in an animal, for stimulating opioid receptor function in a cell, for preparing a composition, and for treating diarrhea in an animal, composition, and kit.
BR0314356A (en) Delayed release formulations for oral administration of a polypeptide therapeutic agent and methods using the same
RS54187B1 (en) Controlled release pharmaceutical compositions comprising a fumaric acid ester
BRPI0113331B8 (en) phenylalanine derivatives or their pharmaceutically acceptable salts, alpha 4 integrin antagonist, therapeutic agent or preventive agent for inflammatory diseases, and pharmaceutical composition
BR0114799A (en) Cyanophenoxy carboxylic acid compounds and compositions for releasing active agents
BR9815499A (en) Prolonged anesthesia in joints and body spaces.
BR0013010A (en) Formulation of moxifloxacin sodium chloride
BR0214610A (en) Controlled release polymeric compositions of bone growth promoting compounds
BR0014383A (en) Controlled release compositions comprising nimesulide
BRPI0507824A (en) hydroxyapatite, process for the preparation of a radionuclide-labeled hydroxyapatite particulate, pharmaceutical composition, use of hydroxyapatite and an alpha-emitting radionuclide or a beta-emitting radionuclide, device, and, method of radiochemical treatment of a human or human individual non-human animal needing the same
BRPI0411241A (en) therapeutic agents useful for treating pain
BRPI0517719A (en) transmucosal veterinary composition comprising detomidine
ES2176487T3 (en) COMPOSITIONS OF COSMETIC AND / OR PHARMACEUTICAL ANTI-PRURIGINAL COMPOUNDS OF ONE OR MISCELLANEOUS LOCAL ANESTHETICS AND ONE OR VARIOUS ASTRINGENTS.
SE0002754D0 (en) New pharmaceutical combination formulation and method of treatment with the combination
AR098251A2 (en) USE OF AIVLOSIN OR AN ACID ADDITION SALT OF THE SAME PHARMACOLOGICALLY ACCEPTED FOR THE PREPARATION OF A VETERINARY USE MEDICINAL PRODUCT, A FOOD FOR CORRAL BIRDS OR PIGS, A STABLE COVERED COMPOSITION TO BE ADDED TO THIS FOOD
TR200002969T2 (en) Pharmaceutical composition.
BR0206576A (en) Pharmaceutical composition containing aminoacetonitrile compounds and their use for the preparation of a pharmaceutical composition for treating endoparasitic pests in animals
BR0010983A (en) Preparations for the application of anti-inflammatory agents
BR9914996A (en) Stimulating compositions for improved growth

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE ESTE NAO ATENDE AOS REQUISITO DE PATENTEABILIDADE CONFORME O DISPOSTO NOS ARTIGOS 8O COMBINADO COM 13 DA LEI 9.279/96.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 01/11/2011, OBSERVADAS AS CONDICOES LEGAIS. NA FOLHA 132, LINHA 29, ONDE SE LE: "...NA ETAPA 9(A) E 9(B); LEIA-SE: "...NAS ETAPAS (A) E (B)"

B25D Requested change of name of applicant approved
B25G Requested change of headquarter approved
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 02/11/99, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 02.11.2019

B16B Notification of grant cancelled [chapter 16.2 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 16.3 NA RPI NO 2635 DE 06/07/2021 POR TER SIDO INDEVIDA, UMA VEZ QUE A PATENTE ESTA RELACIONADA A PRODUTO VETERINARIO.

B21I Extinguishment of a patent or of a certificate of addition of invention: publication cancelled

Free format text: ANULADA A PUBLICACAO CODIGO 21.1 NA RPI NO 2656 DE 30/11/2021 POR TER SIDO INDEVIDA.

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 01/11/2021.